Korea conditionally clears Boehringer/Sanofi asset swap

Korea’s competition watchdog has given pharmaceutical companies Boehringer Ingelheim and Sanofi the go-ahead to exchange their animal health and consumer healthcare businesses, subject to a range of divestments in the country’s animal health markets.


Get unlimited access to all Global Competition Review content